Tag: rexgenero
Rexgenero acquires the key technology and programme assets of aratinga.bio SAS...
Rexgenero, a regenerative medicine company developing advanced cell therapies to treat chronic limb-threatening ischaemia (CLTI), has announced the acquisition of all the key assets...
Rexgenero expands manufacturing of REX-001 cell-based CLI therapy
Rexgenero, a regenerative medicine company developing advanced cell-based therapies to treat critical limb ischaemia (CLI), has announced that it has successfully expanded manufacturing of...
New update on Phase III clinical trials of REX-001 cell-based therapy...
Rexgenero, a regenerative medicine company working to develop cell-based therapies to treat critical limb ischaemia (CLI), has presented an update on its two Phase...
